Amyl nitrates are linked to prolonged bilateral vision loss and retinal damage.

Article

Recreational drugs amyl nitrate and isopropyl nitrate (poppers) are associated with bilateral vision loss and retinal disorders due to damage of the foveal cone outer segments.

Recreational drugs amyl nitrate and isopropyl nitrate (poppers) are associated with bilateral vision loss and retinal disorders due to damage of the foveal cone outer segments, according to a study released by the Archives of Ophthalmology.

A team lead by Dr Isabelle Audo, Clinical Investigation Center, Université Pierre et Marie Curie-Paris, France, conducted a restrospective, observational case series on 6 patients with bilateral vision loss after chronic use of amyl or isopropyl nitrates. The outcome measures included: symptoms, medical history, ophthalmic examination and functional and morphological tests.

All patients examined presented with progressive bilateral vision loss. Two patients experienced central photopsia and initial visual acuities varied from 20/50 to 20/25.

In each patient a bilateral yellow foveal spot was found and was linked to the disruption of the foveal cones' outer segments. After discontinued use of poppers, 4 patients demonstrated significant anatomical and functional improvement.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.